

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of respiratory burst (GO:0060267) | 5.01542981 |
| 2 | glomerular filtration (GO:0003094) | 4.38866508 |
| 3 | transcytosis (GO:0045056) | 4.35126184 |
| 4 | sulfate transmembrane transport (GO:1902358) | 4.16970505 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.03264694 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.90459577 |
| 7 | renal filtration (GO:0097205) | 3.84404042 |
| 8 | regulation of respiratory burst (GO:0060263) | 3.79396687 |
| 9 | cGMP-mediated signaling (GO:0019934) | 3.58966967 |
| 10 | negative regulation of cell killing (GO:0031342) | 3.54320564 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.54320564 |
| 12 | negative regulation of myotube differentiation (GO:0010832) | 3.54009148 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.53506244 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.52769108 |
| 15 | sperm capacitation (GO:0048240) | 3.49303342 |
| 16 | respiratory burst (GO:0045730) | 3.49063507 |
| 17 | ethanol oxidation (GO:0006069) | 3.40561011 |
| 18 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.38279792 |
| 19 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.32088208 |
| 20 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.24156287 |
| 21 | sulfate transport (GO:0008272) | 3.22410483 |
| 22 | intestinal absorption (GO:0050892) | 3.19415045 |
| 23 | detection of other organism (GO:0098543) | 3.19365728 |
| 24 | regulation of guanylate cyclase activity (GO:0031282) | 3.19091097 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.16643609 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 3.16643609 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.16643609 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.16643609 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.16643609 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.16643609 |
| 31 | oligosaccharide biosynthetic process (GO:0009312) | 3.13072242 |
| 32 | detection of bacterium (GO:0016045) | 3.05107589 |
| 33 | positive regulation of pseudopodium assembly (GO:0031274) | 2.98842821 |
| 34 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.97439412 |
| 35 | renal system process involved in regulation of blood volume (GO:0001977) | 2.92311382 |
| 36 | neutrophil activation involved in immune response (GO:0002283) | 2.88276320 |
| 37 | diacylglycerol metabolic process (GO:0046339) | 2.84085823 |
| 38 | * bicarbonate transport (GO:0015701) | 2.83403044 |
| 39 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.76555728 |
| 40 | regulation of pseudopodium assembly (GO:0031272) | 2.76153130 |
| 41 | regulation of intracellular pH (GO:0051453) | 2.75493179 |
| 42 | regulation of cellular extravasation (GO:0002691) | 2.74300527 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 2.72979100 |
| 44 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.71268969 |
| 45 | neutrophil activation (GO:0042119) | 2.67509810 |
| 46 | execution phase of apoptosis (GO:0097194) | 2.67101755 |
| 47 | response to acidic pH (GO:0010447) | 2.66064163 |
| 48 | sodium ion export (GO:0071436) | 2.64048464 |
| 49 | creatine metabolic process (GO:0006600) | 2.63276614 |
| 50 | barbed-end actin filament capping (GO:0051016) | 2.62804759 |
| 51 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.62799377 |
| 52 | cellular response to pH (GO:0071467) | 2.62744166 |
| 53 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.61562482 |
| 54 | endocrine process (GO:0050886) | 2.61562482 |
| 55 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.61562482 |
| 56 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.61433035 |
| 57 | epithelial structure maintenance (GO:0010669) | 2.59839578 |
| 58 | detection of external biotic stimulus (GO:0098581) | 2.58660410 |
| 59 | triglyceride catabolic process (GO:0019433) | 2.58401409 |
| 60 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.58208515 |
| 61 | cellular response to cAMP (GO:0071320) | 2.57034553 |
| 62 | superoxide anion generation (GO:0042554) | 2.52676708 |
| 63 | positive regulation of lipid catabolic process (GO:0050996) | 2.52590724 |
| 64 | leukocyte aggregation (GO:0070486) | 2.52292350 |
| 65 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.50405715 |
| 66 | positive regulation of fatty acid oxidation (GO:0046321) | 2.48168761 |
| 67 | acylglycerol catabolic process (GO:0046464) | 2.48034206 |
| 68 | neutral lipid catabolic process (GO:0046461) | 2.48034206 |
| 69 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.47445570 |
| 70 | NADH metabolic process (GO:0006734) | 2.47396907 |
| 71 | regulation of cellular pH (GO:0030641) | 2.47076093 |
| 72 | actin filament polymerization (GO:0030041) | 2.45115064 |
| 73 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.45004983 |
| 74 | ethanol metabolic process (GO:0006067) | 2.44799290 |
| 75 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.43848941 |
| 76 | glucocorticoid biosynthetic process (GO:0006704) | 2.42106265 |
| 77 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.40100945 |
| 78 | regulation of viral entry into host cell (GO:0046596) | 2.39931960 |
| 79 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.39224856 |
| 80 | phospholipid homeostasis (GO:0055091) | 2.38584266 |
| 81 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.35934111 |
| 82 | flavonoid metabolic process (GO:0009812) | 2.35463905 |
| 83 | regulation of regulated secretory pathway (GO:1903305) | 2.34207153 |
| 84 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.32169971 |
| 85 | regulation of leukocyte degranulation (GO:0043300) | 2.31826696 |
| 86 | negative regulation of protein autophosphorylation (GO:0031953) | 2.31655026 |
| 87 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.31152604 |
| 88 | granulocyte activation (GO:0036230) | 2.31117182 |
| 89 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.28431547 |
| 90 | cellular glucuronidation (GO:0052695) | 2.27251050 |
| 91 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.27057384 |
| 92 | sulfur amino acid catabolic process (GO:0000098) | 2.26501731 |
| 93 | detection of molecule of bacterial origin (GO:0032490) | 2.24740623 |
| 94 | negative regulation of viral entry into host cell (GO:0046597) | 2.24387406 |
| 95 | positive regulation of receptor recycling (GO:0001921) | 2.23686252 |
| 96 | immunoglobulin mediated immune response (GO:0016064) | 2.20126037 |
| 97 | regulation of somitogenesis (GO:0014807) | 2.18950784 |
| 98 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.18164021 |
| 99 | regulation of necrotic cell death (GO:0010939) | 2.17914109 |
| 100 | regulation of systemic arterial blood pressure (GO:0003073) | 2.17823546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.20607988 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.58997362 |
| 3 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.56568141 |
| 4 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.51058699 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.42697305 |
| 6 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.35556565 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.34560098 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.29980612 |
| 9 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.07003836 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.95365576 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.87588704 |
| 12 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.86778282 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.86355685 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76262913 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.75555515 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.74053633 |
| 17 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.70758764 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.68975005 |
| 19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68550972 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.68143306 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.65305450 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62120467 |
| 23 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.62058510 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.57174608 |
| 25 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.49388695 |
| 26 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.48185908 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47270965 |
| 28 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.46903232 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.46445330 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.45250578 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.42623910 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39420619 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37427223 |
| 34 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36222271 |
| 35 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.35204337 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34204069 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32903384 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.29628488 |
| 39 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29557936 |
| 40 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27931912 |
| 41 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27586140 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26732438 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25684664 |
| 44 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.23791065 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23651726 |
| 46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21854643 |
| 47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21124737 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.21066326 |
| 49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20719611 |
| 50 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.20054378 |
| 51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17279782 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16203370 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15279428 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15181035 |
| 55 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13707517 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11864131 |
| 57 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10130886 |
| 58 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08999539 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08613741 |
| 60 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08399876 |
| 61 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08214243 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07055521 |
| 63 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05136735 |
| 64 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.03538025 |
| 65 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.03479077 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03073814 |
| 67 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02127969 |
| 68 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02106152 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01795257 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01771483 |
| 71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00414065 |
| 72 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.00340133 |
| 73 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.00261568 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99586052 |
| 75 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98788681 |
| 76 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98788681 |
| 77 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98085408 |
| 78 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.97950065 |
| 79 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97725892 |
| 80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97664688 |
| 81 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.96404297 |
| 82 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.96317416 |
| 83 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.95498718 |
| 84 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95291994 |
| 85 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94028924 |
| 86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93921547 |
| 87 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.93682903 |
| 88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93232381 |
| 89 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.93193928 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93185949 |
| 91 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.93185749 |
| 92 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.92816170 |
| 93 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92504309 |
| 94 | P68_20966046_ChIP-Seq_HELA_Human | 0.92388063 |
| 95 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92168547 |
| 96 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.92112355 |
| 97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91679940 |
| 98 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.91178269 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90892163 |
| 100 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.90749616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.91637325 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.57417848 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 3.23242584 |
| 4 | MP0003866_abnormal_defecation | 3.10834742 |
| 5 | MP0003303_peritoneal_inflammation | 3.00111073 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.96823653 |
| 7 | MP0005670_abnormal_white_adipose | 2.87486723 |
| 8 | MP0004043_abnormal_pH_regulation | 2.54038453 |
| 9 | MP0003436_decreased_susceptibility_to | 2.36972336 |
| 10 | MP0001663_abnormal_digestive_system | 2.32366699 |
| 11 | MP0010155_abnormal_intestine_physiology | 2.19168433 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.03623410 |
| 13 | MP0005666_abnormal_adipose_tissue | 2.02617543 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 1.92258469 |
| 15 | MP0001664_abnormal_digestion | 1.89851205 |
| 16 | MP0005166_decreased_susceptibility_to | 1.86094054 |
| 17 | MP0005381_digestive/alimentary_phenotyp | 1.85211745 |
| 18 | MP0005025_abnormal_response_to | 1.80953218 |
| 19 | MP0009785_altered_susceptibility_to | 1.71690967 |
| 20 | MP0001765_abnormal_ion_homeostasis | 1.68826170 |
| 21 | MP0001533_abnormal_skeleton_physiology | 1.66970291 |
| 22 | MP0003011_delayed_dark_adaptation | 1.66604856 |
| 23 | MP0002419_abnormal_innate_immunity | 1.64957129 |
| 24 | MP0003868_abnormal_feces_composition | 1.62965977 |
| 25 | MP0001873_stomach_inflammation | 1.61994288 |
| 26 | MP0004130_abnormal_muscle_cell | 1.61634484 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.61471844 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.57511604 |
| 29 | MP0002971_abnormal_brown_adipose | 1.55633382 |
| 30 | MP0000477_abnormal_intestine_morphology | 1.54585863 |
| 31 | MP0005451_abnormal_body_composition | 1.51160529 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.51016060 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.49651841 |
| 34 | MP0003690_abnormal_glial_cell | 1.48977596 |
| 35 | MP0005085_abnormal_gallbladder_physiolo | 1.47268954 |
| 36 | MP0003879_abnormal_hair_cell | 1.46586985 |
| 37 | MP0003828_pulmonary_edema | 1.45003322 |
| 38 | MP0003075_altered_response_to | 1.44575998 |
| 39 | MP0008260_abnormal_autophagy | 1.43734210 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.41854241 |
| 41 | MP0005387_immune_system_phenotype | 1.41755387 |
| 42 | MP0001790_abnormal_immune_system | 1.41755387 |
| 43 | MP0002132_abnormal_respiratory_system | 1.41168910 |
| 44 | MP0000490_abnormal_crypts_of | 1.39169069 |
| 45 | MP0006082_CNS_inflammation | 1.38333435 |
| 46 | MP0005365_abnormal_bile_salt | 1.36353177 |
| 47 | MP0005375_adipose_tissue_phenotype | 1.32994693 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.32739642 |
| 49 | MP0003329_amyloid_beta_deposits | 1.31501073 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.31032571 |
| 51 | MP0004858_abnormal_nervous_system | 1.28684660 |
| 52 | MP0001800_abnormal_humoral_immune | 1.24664262 |
| 53 | MP0009840_abnormal_foam_cell | 1.24295759 |
| 54 | MP0004147_increased_porphyrin_level | 1.23191601 |
| 55 | MP0008004_abnormal_stomach_pH | 1.23002721 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.19676167 |
| 57 | MP0010329_abnormal_lipoprotein_level | 1.16630373 |
| 58 | MP0001501_abnormal_sleep_pattern | 1.12624193 |
| 59 | MP0009115_abnormal_fat_cell | 1.12496861 |
| 60 | MP0005409_darkened_coat_color | 1.11252316 |
| 61 | MP0001819_abnormal_immune_cell | 1.11180784 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 1.10333145 |
| 63 | MP0002420_abnormal_adaptive_immunity | 1.09880183 |
| 64 | MP0002118_abnormal_lipid_homeostasis | 1.09653343 |
| 65 | MP0005000_abnormal_immune_tolerance | 1.09576508 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.08856332 |
| 67 | MP0004947_skin_inflammation | 1.07334743 |
| 68 | MP0005636_abnormal_mineral_homeostasis | 1.06473832 |
| 69 | MP0002723_abnormal_immune_serum | 1.04970130 |
| 70 | MP0002452_abnormal_antigen_presenting | 1.04404914 |
| 71 | MP0005535_abnormal_body_temperature | 1.04225030 |
| 72 | MP0002148_abnormal_hypersensitivity_rea | 1.04199072 |
| 73 | MP0004484_altered_response_of | 1.03204327 |
| 74 | MP0003045_fibrosis | 1.01879377 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 0.99763991 |
| 76 | MP0001835_abnormal_antigen_presentation | 0.98135552 |
| 77 | MP0002796_impaired_skin_barrier | 0.97258252 |
| 78 | MP0001849_ear_inflammation | 0.97229335 |
| 79 | MP0004510_myositis | 0.95097027 |
| 80 | MP0005310_abnormal_salivary_gland | 0.91741868 |
| 81 | MP0002998_abnormal_bone_remodeling | 0.90586158 |
| 82 | MP0003172_abnormal_lysosome_physiology | 0.90348258 |
| 83 | MP0000230_abnormal_systemic_arterial | 0.89183852 |
| 84 | MP0005058_abnormal_lysosome_morphology | 0.86436821 |
| 85 | MP0000249_abnormal_blood_vessel | 0.85470422 |
| 86 | MP0005464_abnormal_platelet_physiology | 0.85387502 |
| 87 | MP0000604_amyloidosis | 0.85241681 |
| 88 | MP0005165_increased_susceptibility_to | 0.83269362 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.82357728 |
| 90 | MP0002009_preneoplasia | 0.78092564 |
| 91 | MP0000685_abnormal_immune_system | 0.76558848 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74527109 |
| 93 | MP0001851_eye_inflammation | 0.74054256 |
| 94 | MP0002166_altered_tumor_susceptibility | 0.73324246 |
| 95 | MP0002405_respiratory_system_inflammati | 0.72908825 |
| 96 | MP0005448_abnormal_energy_balance | 0.71629783 |
| 97 | MP0008874_decreased_physiological_sensi | 0.70698448 |
| 98 | MP0006138_congestive_heart_failure | 0.70524012 |
| 99 | MP0005334_abnormal_fat_pad | 0.70521665 |
| 100 | MP0008469_abnormal_protein_level | 0.69953135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 8.09001870 |
| 2 | Metabolic alkalosis (HP:0200114) | 6.15757082 |
| 3 | Decreased circulating renin level (HP:0003351) | 6.14773120 |
| 4 | Abnormality of renin-angiotensin system (HP:0000847) | 5.70984148 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.28125314 |
| 6 | Abnormality of chloride homeostasis (HP:0011422) | 4.38100106 |
| 7 | Hyperaldosteronism (HP:0000859) | 4.16336123 |
| 8 | Flat acetabular roof (HP:0003180) | 4.13656807 |
| 9 | Alkalosis (HP:0001948) | 3.98929364 |
| 10 | Hyponatremia (HP:0002902) | 3.49689242 |
| 11 | Amyloidosis (HP:0011034) | 3.27527552 |
| 12 | Hemorrhage of the eye (HP:0011885) | 3.26336534 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.20556629 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.19595646 |
| 15 | Spontaneous hematomas (HP:0007420) | 3.14796461 |
| 16 | Ileus (HP:0002595) | 3.00432287 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 3.00153014 |
| 18 | Hypokalemia (HP:0002900) | 3.00118442 |
| 19 | Visceral angiomatosis (HP:0100761) | 2.89978282 |
| 20 | Adrenal overactivity (HP:0002717) | 2.83216348 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 2.82953027 |
| 22 | Abnormality of sodium homeostasis (HP:0010931) | 2.82370802 |
| 23 | Ventricular fibrillation (HP:0001663) | 2.81454249 |
| 24 | Hyperkalemia (HP:0002153) | 2.81172718 |
| 25 | Orchitis (HP:0100796) | 2.78975193 |
| 26 | Myositis (HP:0100614) | 2.76648612 |
| 27 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.73169208 |
| 28 | Abnormality of potassium homeostasis (HP:0011042) | 2.72165825 |
| 29 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.64259472 |
| 30 | Abdominal distention (HP:0003270) | 2.61527754 |
| 31 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.59466489 |
| 32 | Flattened epiphyses (HP:0003071) | 2.55945639 |
| 33 | Polycythemia (HP:0001901) | 2.53745952 |
| 34 | Ankle clonus (HP:0011448) | 2.53480270 |
| 35 | Hemangiomatosis (HP:0007461) | 2.50985659 |
| 36 | Petechiae (HP:0000967) | 2.44990173 |
| 37 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.43666206 |
| 38 | Difficulty running (HP:0009046) | 2.41728344 |
| 39 | Abnormal vertebral ossification (HP:0100569) | 2.37635318 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.36887762 |
| 41 | Syncope (HP:0001279) | 2.34869220 |
| 42 | Hypertriglyceridemia (HP:0002155) | 2.31160345 |
| 43 | Malnutrition (HP:0004395) | 2.30898268 |
| 44 | Growth hormone excess (HP:0000845) | 2.30894540 |
| 45 | Gingivitis (HP:0000230) | 2.30392891 |
| 46 | Abnormal tarsal ossification (HP:0008369) | 2.28897409 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.19947794 |
| 48 | Colitis (HP:0002583) | 2.19360848 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 2.18028207 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 2.17770642 |
| 51 | Optic neuritis (HP:0100653) | 2.17770642 |
| 52 | Flat capital femoral epiphysis (HP:0003370) | 2.15551744 |
| 53 | Spinal cord compression (HP:0002176) | 2.12858913 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.08724758 |
| 55 | Urticaria (HP:0001025) | 2.07322315 |
| 56 | Bundle branch block (HP:0011710) | 2.07217527 |
| 57 | Neonatal short-limb short stature (HP:0008921) | 2.05445597 |
| 58 | Toxemia of pregnancy (HP:0100603) | 1.99832427 |
| 59 | Premature loss of primary teeth (HP:0006323) | 1.99520793 |
| 60 | Hypochromic microcytic anemia (HP:0004840) | 1.97863664 |
| 61 | Muscle fiber splitting (HP:0003555) | 1.96481516 |
| 62 | Cellulitis (HP:0100658) | 1.96291688 |
| 63 | Vertebral clefting (HP:0008428) | 1.93000226 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92613491 |
| 65 | Intrahepatic cholestasis (HP:0001406) | 1.92016832 |
| 66 | Abnormality of carpal bone ossification (HP:0006257) | 1.87463778 |
| 67 | Obstructive lung disease (HP:0006536) | 1.87347130 |
| 68 | Chronic obstructive pulmonary disease (HP:0006510) | 1.87347130 |
| 69 | Axonal loss (HP:0003447) | 1.86254954 |
| 70 | Ventricular arrhythmia (HP:0004308) | 1.85649070 |
| 71 | Increased connective tissue (HP:0009025) | 1.83442511 |
| 72 | Mediastinal lymphadenopathy (HP:0100721) | 1.83021426 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 1.80822965 |
| 74 | Meningitis (HP:0001287) | 1.79768281 |
| 75 | Hypochromic anemia (HP:0001931) | 1.77678724 |
| 76 | Increased variability in muscle fiber diameter (HP:0003557) | 1.77232497 |
| 77 | Increased IgE level (HP:0003212) | 1.76029044 |
| 78 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.75228984 |
| 79 | Gastrointestinal dysmotility (HP:0002579) | 1.74955881 |
| 80 | Vasculitis (HP:0002633) | 1.74873812 |
| 81 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.74873081 |
| 82 | Oligomenorrhea (HP:0000876) | 1.74236376 |
| 83 | Hemoptysis (HP:0002105) | 1.74089762 |
| 84 | Hyporeflexia of lower limbs (HP:0002600) | 1.73168076 |
| 85 | Gingival bleeding (HP:0000225) | 1.73069208 |
| 86 | Hepatosplenomegaly (HP:0001433) | 1.73003302 |
| 87 | Osteomyelitis (HP:0002754) | 1.68943752 |
| 88 | Hyperparathyroidism (HP:0000843) | 1.68378498 |
| 89 | Stomatitis (HP:0010280) | 1.66759332 |
| 90 | Abnormality of the nasal mucosa (HP:0000433) | 1.66716083 |
| 91 | Prolonged bleeding time (HP:0003010) | 1.62768046 |
| 92 | Polygenic inheritance (HP:0010982) | 1.61744105 |
| 93 | Distal lower limb muscle weakness (HP:0009053) | 1.61349849 |
| 94 | Microcytic anemia (HP:0001935) | 1.60869359 |
| 95 | Distal lower limb amyotrophy (HP:0008944) | 1.60307404 |
| 96 | Abnormality of the 1st metacarpal (HP:0010009) | 1.59531885 |
| 97 | Hematochezia (HP:0002573) | 1.58926852 |
| 98 | Breech presentation (HP:0001623) | 1.58697389 |
| 99 | Dehydration (HP:0001944) | 1.58171293 |
| 100 | Chest pain (HP:0100749) | 1.58037564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK1 | 4.21345193 |
| 2 | PIK3CA | 3.99402387 |
| 3 | RIPK4 | 3.98719340 |
| 4 | ERN1 | 3.38127520 |
| 5 | LMTK2 | 2.99063385 |
| 6 | EPHA2 | 2.40205817 |
| 7 | ACVR1B | 2.40079325 |
| 8 | MST1R | 2.12062623 |
| 9 | EPHB1 | 1.90672927 |
| 10 | MAP2K3 | 1.77609964 |
| 11 | IRAK4 | 1.77244080 |
| 12 | CSK | 1.69882099 |
| 13 | PRPF4B | 1.68057895 |
| 14 | KSR2 | 1.67412810 |
| 15 | TAOK1 | 1.66441445 |
| 16 | PTK6 | 1.64470507 |
| 17 | TRIB3 | 1.60572929 |
| 18 | TYK2 | 1.59737373 |
| 19 | MAP4K1 | 1.56675065 |
| 20 | PDPK1 | 1.55617930 |
| 21 | ZAP70 | 1.46500186 |
| 22 | MAP3K11 | 1.44582808 |
| 23 | TNK2 | 1.44579630 |
| 24 | GRK6 | 1.42776401 |
| 25 | FES | 1.42577344 |
| 26 | DAPK2 | 1.42454124 |
| 27 | EPHB2 | 1.36832097 |
| 28 | PRKG2 | 1.36463749 |
| 29 | MAP3K1 | 1.28646762 |
| 30 | EPHA4 | 1.26670192 |
| 31 | PDK1 | 1.21258282 |
| 32 | CDK19 | 1.20519787 |
| 33 | JAK2 | 1.11060513 |
| 34 | BLK | 1.04511500 |
| 35 | SIK3 | 1.03886684 |
| 36 | MAP3K2 | 0.98865565 |
| 37 | FGFR4 | 0.97383992 |
| 38 | TESK1 | 0.97369143 |
| 39 | SIK1 | 0.95811315 |
| 40 | OXSR1 | 0.93500195 |
| 41 | TESK2 | 0.92844905 |
| 42 | DMPK | 0.92827957 |
| 43 | MAP2K6 | 0.92429248 |
| 44 | MAP3K3 | 0.91310204 |
| 45 | SMG1 | 0.88143574 |
| 46 | PRKD2 | 0.87775572 |
| 47 | MAP3K6 | 0.87134635 |
| 48 | MAP2K2 | 0.85419417 |
| 49 | MARK2 | 0.84901789 |
| 50 | HCK | 0.80717070 |
| 51 | PRKAA2 | 0.77591002 |
| 52 | PDK2 | 0.77430674 |
| 53 | FGR | 0.75135354 |
| 54 | MAPK12 | 0.75065234 |
| 55 | NTRK3 | 0.73529009 |
| 56 | MAP3K12 | 0.72444184 |
| 57 | MAP2K4 | 0.71602454 |
| 58 | TBK1 | 0.70547587 |
| 59 | YES1 | 0.70198398 |
| 60 | CDC42BPA | 0.69209838 |
| 61 | RET | 0.65027284 |
| 62 | MAP3K13 | 0.65009306 |
| 63 | STK38 | 0.63413915 |
| 64 | ABL2 | 0.62860740 |
| 65 | JAK1 | 0.61728944 |
| 66 | STK24 | 0.60490311 |
| 67 | GRK5 | 0.59796101 |
| 68 | LYN | 0.58602117 |
| 69 | MYLK | 0.57414826 |
| 70 | FYN | 0.54713149 |
| 71 | CAMK1 | 0.53089439 |
| 72 | STK11 | 0.52567274 |
| 73 | ARAF | 0.51949707 |
| 74 | EPHA3 | 0.51355772 |
| 75 | CAMKK1 | 0.50509543 |
| 76 | IKBKE | 0.50497200 |
| 77 | SYK | 0.50057195 |
| 78 | MAP2K1 | 0.49681120 |
| 79 | FGFR3 | 0.48750510 |
| 80 | CAMK2D | 0.48074464 |
| 81 | LRRK2 | 0.47992208 |
| 82 | MATK | 0.46714861 |
| 83 | PAK6 | 0.45815213 |
| 84 | JAK3 | 0.45039784 |
| 85 | TAOK2 | 0.44913841 |
| 86 | BTK | 0.43909545 |
| 87 | DYRK1B | 0.43752732 |
| 88 | TIE1 | 0.43496748 |
| 89 | PRKCZ | 0.43366739 |
| 90 | IRAK1 | 0.42984771 |
| 91 | STK39 | 0.42056079 |
| 92 | DDR2 | 0.40514758 |
| 93 | MAPK7 | 0.40441748 |
| 94 | MET | 0.40269683 |
| 95 | IRAK2 | 0.40018096 |
| 96 | SGK3 | 0.39378592 |
| 97 | FER | 0.38922241 |
| 98 | PRKD1 | 0.37913133 |
| 99 | TTN | 0.33144434 |
| 100 | SRC | 0.32771811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.86317513 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.80003473 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.34352226 |
| 4 | * Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.30952792 |
| 5 | * Nitrogen metabolism_Homo sapiens_hsa00910 | 2.22789034 |
| 6 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.15528263 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.94879823 |
| 8 | Mineral absorption_Homo sapiens_hsa04978 | 1.81043680 |
| 9 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.76610729 |
| 10 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.59373663 |
| 11 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.56748902 |
| 12 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.53158065 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.48233978 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.47536070 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45199013 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39306714 |
| 17 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.38788080 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.38247325 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.37930016 |
| 20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.33121987 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.28527198 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.26593624 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.24513586 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21113640 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.11778940 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.06130714 |
| 27 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01319618 |
| 28 | Hepatitis C_Homo sapiens_hsa05160 | 1.00266581 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 0.97010342 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 0.95413201 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92546171 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90354749 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88068990 |
| 34 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87614406 |
| 35 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87187260 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86453744 |
| 37 | Long-term potentiation_Homo sapiens_hsa04720 | 0.86190623 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.84788280 |
| 39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84491025 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.82141736 |
| 41 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73192271 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.72970097 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72847740 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72684498 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72662004 |
| 46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70808600 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.68864146 |
| 48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68672618 |
| 49 | Tight junction_Homo sapiens_hsa04530 | 0.68295768 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63987433 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63453233 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62722336 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.62449995 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62216837 |
| 55 | Endocytosis_Homo sapiens_hsa04144 | 0.61285087 |
| 56 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61126842 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60157714 |
| 58 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.59322303 |
| 59 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58882282 |
| 60 | Malaria_Homo sapiens_hsa05144 | 0.58834596 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.58548988 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57623857 |
| 63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57131072 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55912861 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54703866 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54617522 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54305206 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.53817646 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51361290 |
| 70 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.50822043 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.50674521 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50612830 |
| 73 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50464440 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50340257 |
| 75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50261550 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49675941 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49437074 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.49365042 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48770155 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48527563 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47937161 |
| 82 | Allograft rejection_Homo sapiens_hsa05330 | 0.46422477 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45252818 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.44693720 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43603294 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43516462 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42346010 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.42342132 |
| 89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.41724952 |
| 90 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40181698 |
| 91 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39608309 |
| 92 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.39454855 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.38482372 |
| 94 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37391316 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36572098 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36210985 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36088508 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35140019 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35096145 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34228261 |

